Evidence mapPaperPMID 41438951Full record

ArticleFindings of ACL. EMNLP. Conference on Empirical Methods in Natural Language Processing2024

DALK: Dynamic Co-Augmentation of LLMs and KG to answer Alzheimer's Disease Questions with Scientific Literature.

Dawei Li, Shu Yang, Zhen Tan, Jae Young Baik, Sukwon Yun, Joseph Lee, Aaron Chacko, Bojian Hou, Duy Duong-Tran, Ying Ding and 3 more

Abstract read
In one paragraph

Article in Findings of ACL. EMNLP. Conference on Empirical Methods in Natural Language Processing, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. A survey on LLM-as-a-judge.Innovation (Cambridge (Mass.)) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Time Matters: Examine Temporal Effects on Biomedical Language Models.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dawei LiSchool of Computing, and Augmented Intelligence, Arizona State University.
Shu YangUniversity of Pennsylvania Perelman School of Medicine.
Zhen TanSchool of Computing, and Augmented Intelligence, Arizona State University.
Jae Young BaikUniversity of Pennsylvania Perelman School of Medicine.
Sukwon YunDepartment of Computer Science, The University of North Carolina at Chapel Hill.
Joseph LeeUniversity of Pennsylvania Perelman School of Medicine.
Aaron ChackoUniversity of Pennsylvania Perelman School of Medicine.
Bojian HouUniversity of Pennsylvania Perelman School of Medicine.
Duy Duong-TranUniversity of Pennsylvania Perelman School of Medicine.
Ying DingSchool of Information, The University of Texas at Austin, Austin.
Huan LiuSchool of Computing, and Augmented Intelligence, Arizona State University.
Li ShenUniversity of Pennsylvania Perelman School of Medicine.
Tianlong ChenDepartment of Computer Science, The University of North Carolina at Chapel Hill.

Funding

Technology Identification and Training CoreP30AG073105 · UNIVERSITY OF PENNSYLVANIA · 2025 to 2025
$4.0M
Artificial Intelligence Strategies for Alzheimer's Disease ResearchU01AG066833 · CEDARS-SINAI MEDICAL CENTER · 2025 to 2025
$1.6M
Translational big data analytic approaches to advance drug repurposing for Alzheimer's diseaseR01AG071470 · UNIVERSITY OF PENNSYLVANIA · 2025 to 2025
$715k
NIA NIH HHS P30 AG073105NIA NIH HHS R01 AG071470NIA NIH HHS U01 AG066833NIA NIH HHS U01 AG068057
6 · The paper itself

Abstract

Recent advancements in large language models (LLMs) have achieved promising performances across various applications. Nonetheless, the ongoing challenge of integrating long-tail knowledge continues to impede the seamless adoption of LLMs in specialized domains. In this work, we introduce DALK, a.k.a. Dynamic Co-Augmentation of LLMs and KG, to address this limitation and demonstrate its ability on studying Alzheimer's Disease (AD), a specialized sub-field in biomedicine and a global health priority. With a synergized framework of LLM and KG mutually enhancing each other, we first leverage LLM to construct an evolving AD-specific knowledge graph (KG) sourced from AD-related scientific literature, and then we utilize a coarse-to-fine sampling method with a novel self-aware knowledge retrieval approach to select appropriate knowledge from the KG to augment LLM inference capabilities. The experimental results, conducted on our constructed AD question answering (ADQA) benchmark, underscore the efficacy of DALK. Additionally, we perform a series of detailed analyses that can offer valuable insights and guidelines for the emerging topic of mutually enhancing KG and LLM.

Identifiers

PMID41438951
PMCPMC12720203

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.